Etienne: From Oncology Breakthroughs to Fantasy Football Standouts in 2025

Etienne Brain: Shaping the Future of Geriatric Oncology in Europe

In the bustling corridors of Institut Curie/Saint-Cloud, Dr. Etienne Brain is not just a senior medical oncologist—he’s a guiding light for the evolving field of geriatric oncology. For more than two decades, Dr. Brain has focused his career on improving cancer care for older adults, particularly those diagnosed with breast cancer. His journey, which began at Université René Descartes in Paris, took him across the Atlantic for advanced research at Dana-Farber Cancer Institute and Boston University. There, he honed his expertise in cancer pharmacology, exploring how treatments interact with the aging body—a question that grows more urgent as populations worldwide age.

Dr. Brain’s credentials speak volumes: MD, PhD, and further specialization in health economics at Bocconi University. But it’s his impact beyond the degrees that sets him apart. At Institut Curie, he has driven clinical research and multidisciplinary care, pushing for innovative strategies that account for frailty, competing health risks, and the often-overlooked complexities of treating cancer in older patients. As chair of the GERICO group and DIALOG Intergroup, he has shaped policy and practice nationwide, collaborating with the French National Cancer Institute (INCa) to ensure research translates into better outcomes.

His influence extends internationally. Dr. Brain chaired the EORTC Breast Cancer Group and, since 2021, serves as Secretary General of the European Organisation for Research and Treatment of Cancer (EORTC). He is also part of the executive board for the Breast International Group (BIG), where his input steers major clinical trials. The ASTER 70s trial, led by Dr. Brain, stands as a landmark achievement: the largest study to date on adjuvant chemotherapy for women aged 70+ with luminal breast cancer. Presented at the 2022 ASCO annual meeting, its results have become a benchmark for clinicians worldwide. Recognition followed—B.J. Kennedy Award for Scientific Excellence in Geriatric Oncology, the Michel Hery Geriatric Oncology Award, and the Prix Albert Ier from the Académie Nationale de Médecine. These honors highlight his scientific rigor and commitment to transforming care for older adults.

Dr. Brain’s leadership isn’t confined to research. He has served as Deputy Director for Research at René Huguenin Cancer Centre, chaired evaluation committees at Institut Curie, and co-headed geriatric oncology coordination with Hôpital Européen Georges Pompidou. His presidency of the International Society of Geriatric Oncology (SIOG) further cemented his role in global education and advocacy. As a prolific author, his work appears in prestigious journals—Lancet Oncology, JAMA, Annals of Oncology, Journal of Clinical Oncology—while he shapes the field as an editorial board member for The Breast and the Journal of Geriatric Oncology, and an active participant in ESMO and ASCO.

Travis Etienne Jr.: Fantasy Football’s Reliable Asset

Meanwhile, in a different arena altogether, the name Etienne resonates for NFL fans and fantasy football managers. Travis Etienne Jr., the Jacksonville Jaguars’ dynamic running back, continues to make waves in the 2025 season. Heading into Week 13 against the Tennessee Titans, Etienne is healthy, off the injury report, and projected to be a key contributor. Last week’s performance—a 15-yard touchdown reception and 116 all-purpose yards—quieted concerns about a split backfield, reaffirming his status as the team’s RB1.

Fantasy analysts expect Etienne to log another high-usage game, projecting 16–18 carries and several targets. With eight top-20 finishes this season, he remains a critical mid-round draft pick for those chasing league championships. His consistency in PPR formats—15.2 points projected in Week 13—makes him a staple in lineups, especially with favorable weather conditions (49°F, 11 mph winds) at kickoff. As Jacksonville pushes toward the playoffs, Etienne’s reliability is a cornerstone for managers looking for every edge.

Draft picks like Jahmy Gibbs and Jaxon Smith-Njigba might steal headlines with explosive performances, but Etienne’s steady production is a reminder: sometimes, the difference between victory and defeat is a player who delivers week after week, no drama required. The Jaguars’ playoff hopes hinge on contributions like his, and fantasy managers know the value of a dependable RB in December.

Two Etiennes, Two Legacies: Excellence in Distinct Fields

It’s easy to overlook the coincidence of shared names, but there’s a deeper narrative here—a story about what it means to excel, regardless of the playing field. Dr. Etienne Brain and Travis Etienne Jr. have little in common beyond their name and a commitment to their crafts. Yet both show that progress, whether measured in survival rates or rushing yards, is built on discipline, resilience, and the ability to adapt.

Dr. Brain’s work transforms lives at a systemic level. His advocacy for older adults in cancer research challenges assumptions, pushing medicine to be both more compassionate and more precise. Travis Etienne Jr.’s athletic achievements, meanwhile, are a testament to preparation, teamwork, and grit—the qualities that define successful competitors in any discipline.

From oncology conference halls in Paris to stadiums in Tennessee, the name Etienne is a reminder: leadership is not about fame, but about impact. Whether advancing cancer care or securing a fantasy football win, their stories offer lessons in perseverance and strategic thinking.

As 2025 unfolds, Etienne stands for more than just a name—it’s a symbol of excellence, innovation, and reliability. In both science and sport, the legacy is clear: progress depends not just on talent, but on the willingness to lead, adapt, and deliver when it matters most.